abstract |
A composition comprising: (a) at least one inhibitor of the absorption of pharmaceutically acceptable sterols or salts or pharmaceutically acceptable solvates thereof; and (b) at least one cardiovascular agent for treating vascular disorders that is different from at least one steril absorption inhibitor; wherein the at least one sterols absorption inhibitor is represented by Formula (I): or isomers thereof, or pharmaceutically acceptable salts or solvates of the compounds of Formula (I) or isomers thereof, wherein: Ar1 and Ar2 are independently selected from the group consisting of an aryl and R4-substituted aryl group; Ar3 is aryl or R5-substituted aryl. |